Surv Ophthalmol 2000, 45 (2) : 115–134.CrossRefPubMed 13. Blanco PL, Marshall JC, Antecka E, Callejo SA, Souza Filho JP, Saraiva V, Burnier MN Jr: Characterization of ocular and metastatic
uveal melanoma in an animal model. Invest Ophthalmol Vis Sci 2005, 46 (12) : 4376–4382.CrossRefPubMed 14. De Waard-Siebinga I, Blom DJ, Griffioen M, Schrier PI, Hoogendoorn E, Beverstock G, Danen EH, Jager MJ: Establishment and characterization of an uveal-melanoma cell line. Int J Cancer 1995, 62 (2) : 155–161.CrossRefPubMed 15. Marshall JC, Caissie AL, Callejo find more SA, Antecka E, Burnier MN Jr: Cell proliferation profile of five human uveal melanoma cell lines of different metastatic potential. Pathobiology 2004, 71 (5) : 241–245.CrossRefPubMed 16. Steuhl KP, Rohrbach JM, Knorr M, Thiel HJ: Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors. Ophthalmology 1993, 100 (2) : 208–215.PubMed 17. Burnier
MN Jr, McLean IW, Gamel JW: Immunohistochemical Adriamycin datasheet evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase. Cancer 1991, 68 (4) : 809–814.CrossRefPubMed 18. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990, 82 (13) : 1107–1112.CrossRefPubMed 19. Shields CL: The hunt for the secrets of uveal melanoma. Clin Experiment Ophthalmol 2008, 36 (3) : 277–280.CrossRefPubMed 20. Shah CP, Weis E, Lajous M, Shields JA, Shields CL: Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology 2005, 112 (9) : 1599–1607.CrossRefPubMed 21. Smith JH, Padnick-Silver L, Newlin A, Rhodes K, Rubinstein WS: Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi. Ophthalmology 2007, 114 (4) : 774–779.CrossRefPubMed 22. Holly EA, Aston DA, Char DH, Kristiansen JJ, Ahn DK: Uveal melanoma in relation to ultraviolet light exposure and host factors.
Cancer Res 1990, 50 (18) : 5773–5777.PubMed 23. Csoma Z, Hencz P, Orvos H, Kemeny L, Dobozy A, Dosa-Racz E, Erdei Z, Bartusek D, Olah J: Neonatal HDAC inhibitor blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics Pembrolizumab purchase 2007, 119 (5) : 1036–1037. author reply 1037–1038CrossRefPubMed 24. Matichard E, Le Henanff A, Sanders A, Leguyadec J, Crickx B, Descamps V: Effect of neonatal phototherapy on melanocytic nevus count in children. Arch Dermatol 2006, 142 (12) : 1599–1604.CrossRefPubMed 25. Ranjan M, Beedu SR: Spectroscopic and biochemical correlations during the course of human lens aging. BMC ophthalmology 2006, 6: 10.CrossRefPubMed 26. Spencer WH, American Academy of Ophthalmology: Ophthalmic pathology: an atlas and textbook. In Ophthalmic pathology: an atlas and textbook. 4th edition. Philadelphia; London: Saunders; 1996:2121–2168.